S5YA Stock Chart & Stats
€1.66
€0.00(0.00%)
At close: 4:00 PM EST
€1.66
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.50 - €1.83
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€19.06B
Enterprise Value€35.61B
Total Cash (Recent Filing)€163.13M
Total Debt (Recent Filing)€3.04B
Price to Earnings (P/E)125.7
Beta-0.17
Next Earnings
Aug 27, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding11,543,703,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.09
Price to Book (P/B)5.38
Price to Sales (P/S)0.92
P/FCF Ratio-13.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.99Price Target Upside20.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)0.05
Revenue Forecast (FY)€7.24B
Bulls Say, Bears Say
Bulls Say
Comparable Store SalesComparable store sales growth exceeded expectations, supporting an analyst's overweight rating and signaling continued top-line strength.
International Expansion And DistributionStrong international sales performance supports plans for increased investment in new markets and for building additional distribution infrastructure as existing arrangements end.
Store Roll-outs And ConversionsSteady progress with store roll-outs and conversions, combined with sustained same-store sales, underpins an analyst's positive view on long-term revenue expansion.
Bears Say
Delayed Margin ExpansionAnalyst warns margin expansion could be delayed because most cost synergies are projected to be realized further out and supply-chain savings remain modest.
New Zealand Wholesaling InternalizationAnalyst cautions that internalizing wholesaling and equity arrangements in New Zealand may reduce the group's overall profit margin.
Operational Leverage ShortfallAnalyst notes lower-than-expected operational leverage, suggesting earnings growth may lag behind network sales expansion.
S5YA FAQ
What was Sigma Healthcare Ltd’s price range in the past 12 months?
Sigma Healthcare Ltd lowest stock price was €1.50 and its highest was €1.83 in the past 12 months.
What is Sigma Healthcare Ltd’s market cap?
Sigma Healthcare Ltd’s market cap is €19.06B.
When is Sigma Healthcare Ltd’s upcoming earnings report date?
Sigma Healthcare Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 56 days.
How were Sigma Healthcare Ltd’s earnings last quarter?
Sigma Healthcare Ltd released its earnings results on Feb 25, 2026. The company reported €0.021 earnings per share for the quarter, missing the consensus estimate of €0.021 by >-€0.001.
Is Sigma Healthcare Ltd overvalued?
According to Wall Street analysts Sigma Healthcare Ltd’s price is currently Undervalued.
Does Sigma Healthcare Ltd pay dividends?
Sigma Healthcare Ltd does not currently pay dividends.
What is Sigma Healthcare Ltd’s EPS estimate?
Sigma Healthcare Ltd’s EPS estimate is 0.02.
How many shares outstanding does Sigma Healthcare Ltd have?
Sigma Healthcare Ltd has 11,543,703,000 shares outstanding.
What happened to Sigma Healthcare Ltd’s price movement after its last earnings report?
Sigma Healthcare Ltd reported an EPS of €0.021 in its last earnings report, missing expectations of €0.021. Following the earnings report the stock price went down -1.661%.
Which hedge fund is a major shareholder of Sigma Healthcare Ltd?
Currently, no hedge funds are holding shares in DE:S5YA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sigma Healthcare Ltd Stock Smart Score
Company Description
Sigma Healthcare Ltd
Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
S5YA Stock 12 Month Forecast
Average Price Target
€1.99
▲(20.00% Upside)
Technical Analysis
Mayne Pharma Group
―
CSL
―
Nanosonics Limited
―
Paragon Care Limited
―
Althea Group Holdings Ltd.
―
Options Prices
Currently, No data available
---







